V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007106 | 310004278 | 1.81 | 82.35 | Palliative (P) | 2013-02-06 | 2013-03-26 | PEMBROLIZUMAB | Y | null | 310015793 | PEMBROLIZUMAB |
| 310007107 | 310004278 | 1.79 | null | Palliative (P) | 2018-07-24 | 2018-07-27 | CISPLATIN + GEMCITABINE | 02 | N | 310015793 | CISPLATIN + GEMCITABINE |
| 310007108 | 310004278 | 1.82 | null | Palliative (P) | 2013-06-26 | 2013-07-13 | PEMBROLIZUMAB | N | N | 310015793 | PEMBROLIZUMAB |
| 310007109 | 310004279 | 1.76 | 71.2 | Curative (C) | 2017-12-26 | 2018-01-02 | Mini BEAM | 02 | N | 310015836 | BEAM |
| 310007110 | 310007787 | 1.63 | 42.8 | Palliative (P) | 2017-09-29 | 2017-09-29 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310015842 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007111 | 310004280 | 1.5 | 13 | Curative (C) | 2013-10-29 | 2013-10-29 | IVE | N | N | 310015845 | IVE |
| 310007112 | 310004281 | 1.5 | 52.4 | Curative (C) | 2015-12-29 | 2016-01-19 | Mini BEAM | 02 | N | 310015861 | BEAM |
| 310007113 | 310004282 | 1.86 | 88.8 | Palliative (P) | 2013-09-20 | 2014-04-08 | CISPLATIN + GEMCITABINE | 02 | N | 310015863 | CISPLATIN + GEMCITABINE |
| 310007114 | 310004282 | null | 58.4 | null | 2013-07-03 | 2013-07-09 | CISPLATIN + GEMCITABINE | 02 | Y | 310015863 | CISPLATIN + GEMCITABINE |
| 310007115 | 310004283 | 1.19 | 135.4 | Palliative (P) | 2013-08-04 | 2013-08-08 | null | N | N | 310015877 | NOT MATCHED |
| 310007116 | 310004284 | 1.94 | 89 | Palliative (P) | 2018-07-17 | 2018-07-18 | Gemcitabine day 1&8 | N | null | 310015889 | GEMCITABINE |
| 310007117 | 310004285 | 1.75 | 75.9 | Palliative (P) | 2018-01-19 | 2018-01-19 | Gemcitabine weekly | 02 | N | 310015897 | GEMCITABINE |
| 310007118 | 310004286 | 1.78 | 53.2 | Disease modification (D) | 2013-11-26 | 2013-11-26 | LEAM | 02 | N | 310015897 | LEAM |
| 310007119 | 310004287 | 1.65 | 101.2 | Palliative (P) | 2013-08-09 | 2013-08-09 | NB HRNBL-1 TVD | N | N | 310015911 | NOT MATCHED |
| 310007120 | 310004287 | null | 44 | Curative (C) | 2018-09-09 | 2018-09-16 | IVE | 02 | N | 310015911 | IVE |
| 310007121 | 310004288 | null | null | Palliative (P) | 2015-01-09 | 2015-01-10 | PEMBROLIZUMAB | N | N | 310015915 | PEMBROLIZUMAB |
| 310007122 | 310004288 | 1.8 | 100.6 | Palliative (P) | 2017-03-14 | 2017-04-05 | GEMCITABINE | N | N | 310015915 | GEMCITABINE |
| 310007123 | 310004288 | 1.73 | 132.8 | Palliative (P) | 2016-02-24 | 2016-02-24 | Carboplatin + Liposomal Doxorubicin | N | N | 310015915 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007124 | 310004288 | 1.88 | 81.7 | Curative (C) | 2016-07-02 | 2016-07-08 | BEAM | null | N | 310015915 | BEAM |
| 310007125 | 310004288 | null | null | Palliative (P) | 2017-09-09 | 2018-03-10 | PEMBROLIZUMAB | Y | N | 310015915 | PEMBROLIZUMAB |
| 310007126 | 310004289 | null | 94 | Curative (C) | 2016-08-26 | 2016-10-23 | Brentuximab Vedotin | N | N | 310015971 | BRENTUXIMAB |
| 310007127 | 310004291 | null | 63.9 | Palliative (P) | 2012-04-07 | 2015-02-05 | ETOPOSIDE + GEMCITABINE + IFOSFAMIDE | 02 | N | 310015985 | NOT MATCHED |
| 310007128 | 310004293 | 1.58 | 70.1 | Palliative (P) | 2017-12-15 | 2017-12-27 | Brentuximab | N | N | 310015995 | BRENTUXIMAB |
| 310007129 | 310004294 | null | 0 | Palliative (P) | 2015-01-20 | 2015-01-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016015 | CISPLATIN + GEMCITABINE |
| 310007130 | 310004294 | null | 68.5 | Disease modification (D) | null | 2017-01-15 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 310016015 | NOT MATCHED |
| 310007132 | 310004298 | null | 13.4 | Palliative (P) | 2018-02-12 | 2018-02-13 | null | 02 | N | 310016049 | NOT MATCHED |
| 310007133 | 310004299 | 1.84 | 64 | Curative (C) | 2017-02-06 | 2017-04-09 | IVE | N | N | 310016050 | IVE |
| 310007134 | 310004300 | 1.69 | 80.5 | Curative (C) | 2014-06-28 | 2014-07-02 | IVE | 02 | N | 310016050 | IVE |
| 310007135 | 310004301 | 1.78 | 65.9 | Palliative (P) | 2016-11-05 | 2016-11-26 | Mini BEAM | N | N | 310016104 | BEAM |
| 310007136 | 310004302 | 1.87 | 84.5 | Curative (C) | 2013-12-22 | 2014-01-05 | BEAM | 02 | N | 310016112 | BEAM |
| 310007137 | 310004305 | 1.7 | 54 | Curative (C) | 2017-09-03 | 2017-10-09 | GEMCITABINE | N | N | 310016118 | GEMCITABINE |
| 310007138 | 310004307 | 1.7 | 74.2 | Palliative (P) | 2018-01-31 | 2018-03-02 | Carboplatin + Liposomal Doxorubicin | N | N | 310016129 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007139 | 310007799 | 1.19 | 69.3 | Palliative (P) | 2017-09-16 | 2017-10-09 | NB HRNBL-1 BUMEL MAT | N | N | 310016135 | NOT MATCHED |
| 310007140 | 310004310 | 1.91 | 70.4 | Curative (C) | 2014-04-28 | 2014-12-13 | GEM-P | 2 | N | 310016142 | GEMCITABINE + PACLITAXEL |
| 310007141 | 310004311 | 1.77 | 73.5 | Palliative (P) | 2017-06-02 | 2017-06-17 | GEM-P | N | N | 310016142 | GEMCITABINE + PACLITAXEL |
| 310007142 | 310010658 | 1.78 | 104 | Curative (C) | 2017-10-23 | 2017-11-02 | LEAM | 02 | N | 310016157 | LEAM |
| 310007143 | 310010658 | 1.19 | 54.1 | Palliative (P) | 2014-04-10 | 2014-04-14 | MASITINIB | N | N | 310016157 | NOT MATCHED |
| 310007144 | 310010658 | 1.79 | 89.6 | Curative (C) | 2014-02-18 | 2014-02-18 | IVE | N | N | 310016157 | IVE |
| 310007145 | 310004312 | 1.5 | 70 | Palliative (P) | 2018-09-15 | 2018-10-07 | Carboplatin + Liposomal Doxorubicin | N | N | 310016182 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007146 | 310004313 | 1.56 | 60.4 | Disease modification (D) | 2014-01-03 | 2014-01-05 | Carboplatin + Liposomal Doxorubicin | N | N | 310016192 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007147 | 310007802 | 1.82 | 80 | Not known (9) | 2016-11-11 | 2016-11-11 | PEMBROLIZUMAB | N | N | 310016192 | PEMBROLIZUMAB |
| 310007148 | 310007802 | 1.78 | 94 | null | 2017-07-26 | 2018-01-16 | GEM-P | 02 | N | 310016192 | GEMCITABINE + PACLITAXEL |
| 310007149 | 310004315 | 1.78 | null | Palliative (P) | 2017-05-23 | 2017-06-05 | LEAM | N | N | 310016212 | LEAM |
| 310007150 | 310007803 | 1.64 | 68.1 | Palliative (P) | 2016-06-26 | 2016-06-28 | CISPLATIN + GEMCITABINE | N | null | 310016217 | CISPLATIN + GEMCITABINE |
| 310007151 | 310004317 | 1.63 | 117.3 | null | 2019-01-31 | 2019-02-14 | Gemcitabine weekly | N | N | 310016231 | GEMCITABINE |
| 310007152 | 310007805 | 1.59 | 52.6 | Palliative (P) | 2016-01-08 | 2016-01-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310016247 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007153 | 310007805 | 1.8 | 85.4 | Palliative (P) | 2015-02-16 | 2015-02-16 | GEM-P | 2 | N | 310016247 | GEMCITABINE + PACLITAXEL |
| 310007154 | 310007805 | 1.75 | 100.4 | Palliative (P) | 2015-08-17 | 2015-08-21 | GEMCITABINE | N | N | 310016247 | GEMCITABINE |
| 310007155 | 310004322 | 1.6 | 52.4 | Palliative (P) | 2013-06-05 | 2013-06-05 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310016285 | GEMCITABINE |
| 310007156 | 310009667 | null | 77 | Palliative (P) | 2015-01-14 | 2015-01-21 | CNS Pineoblastoma guidelines Vinc/Etop/Cyclophos | N | N | 310016301 | NOT MATCHED |